CARLSBAD, CALIFORNIA--(Marketwired - Oct. 10, 2014) - Aurora Spine Corporation (TSX VENTURE:ASG) is excited to announce the launch of another new product in its line of next generation MIS lumbar interbody cages. EOS™ is Aurora Spine's modern, minimally invasive TLIF interbody fusion system featuring TiNano titanium spray coating technology. TiNano coated PEEK-OPTIMA cages will allow for the possibility of bone ongrowth due to its porous structure.

"The MIS EOS Interbody System (TLIF) is a fundamental part of Aurora's expanding TiNano Interbody portfolio," said Bryan Okamoto, Aurora Spine's Engineering Manager. "Using a traditional TLIF approach, the EOS system features cages with a self-distracting nose and an articulating cage inserter which aids in establishing optimal cage placement in addition to all the benefits of the TiNano coating. The addition of this new system will continue to solidify Aurora's TiNano Interbody products in the marketplace."

The TiNano surface is created by thermal spray technology of Titanium particles to support osseointegration. TiNano coated cages provide several advantages including: additional roughness and porosity, increased possibility of bone ongrowth and enhanced radiographic visibility. TiNano will be available on all Aurora interbody cages, including Cervical, PLIF, OLIF, TLIF, ALIF and LLIF.

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of its securities about important factors that could cause the company's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.